Drug Reference

Bupropion / Naltrexone

Centrally acting antiobesity products

Fact box

Therapeutic class: Centrally acting antiobesity products

Brand names

Contrave

Available as

90 MG · Extended Release Oral Tablet

Multi-ingredient product

BupropionNaltrexone

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

CONTRAVE EXTENDED-RELEASE (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [NALPROPION PHARMACEUTICALS LLC]
CONTRAVE EXTENDED-RELEASE (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS]

2 marketed products on record (RxNorm)

Authoritative sources

DailyMed — current FDA labeling →
LactMed — breastfeeding safety (NLM) →
MedlinePlus — plain-language drug info →
RxNorm (NLM) →

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.